Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK8 | P49336 | 2/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.32 |
| ▸ | CDK2 | P24941 | 4/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.32 |
| ▸ | AXL | P30530 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20925282 | 0.78 | L3MBTL1 (0.33) | CDK8ROCK1KDM4EFLT1CDK9 | |
| SCHEMBL12759604 | 0.78 | CDK2 (0.46) | CDK8ROCK1CHEK1MAP4K4CSF1R | |
| SCHEMBL12759637 | 0.78 | CDK8 (0.32) | CDK8ROCK1CHEK1MAP4K4CSF1R | |
| SCHEMBL841215 | 0.77 | ABL1 (0.32) | KDM4EADORA2APTAFR | |
| SCHEMBL12759633 | 0.76 | SMPD3 (0.36) | CHEK1DYRK1AKDM4ELIMK1CLK4 | |
| SCHEMBL12759645 | 0.76 | PDE3B (0.49) | CDK8ROCK1CHEK1MAP4K4CSF1R | |
| SCHEMBL12759631 | 0.75 | ADORA2A (0.41) | CDK8ROCK1CHEK1MAP4K4CSF1R | |
| SCHEMBL31636869 | 0.74 | PIK3CG (0.34) | ACVR1DYRK1A | |
| SCHEMBL12145248 | 0.74 | ADORA2A (0.38) | CDK8ROCK1CHEK1MAP4K4CSF1R | |
| SCHEMBL16328882 | 0.73 | PTPN11 (0.36) | NPC1RAB9APDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3915996-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20240090312-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-03-14 | — | — | US | disclosed |
| US-11744142-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-11744142-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-11744142-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| EP-3741768-B1 | STABILIZED IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-3741768-B1 | STABILIZED IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2022-12-07 | — | — | EP | disclosed |
| US-11495754-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-08 | — | — | US | disclosed |
| EP-3915996-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2021-12-01 | — | — | EP | disclosed |
| EP-3915996-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2021-12-01 | — | — | EP | disclosed |
| US-8691988-B2 | Metal complexes of cyclometallated imidazo (1,2-f) phenanthridine (1,2-a:1′, 2′-c),quinazoline ligands and isoelectronic and benzannulated analogs thereof | UNIVERSAL DISPLAY CORPORATION (US) | 2014-04-08 | — | — | US | disclosed |
| US-20130310561-A1 | METAL COMPLEXES OF CYCLOMETALLATED IMIDAZO (1,2-f ) PHENANTHRIDINE AND DIIMIDAZO (1,2-a:1', 2'-c),QUINAZOLINE LIGANDS AND ISOELECTRONIC AND BENZANNULATED ANALOGS THEREOF | UNIVERSAL DISPLAY CORPORATION (US) | 2013-11-21 | — | — | US | disclosed |
| US-8142909-B2 | Blue phosphorescent imidazophenanthridine materials | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| EP-2399922-A1 | Metal complexes of cyclometallated imidazo(1,2-f) phenanthridine and diimidazo(1,2-A;1',2'-C)quinazoline ligands and isoelectronic and benzannulated analogs therof | Universal Display Corporation (US) | 2011-12-28 | — | — | EP | disclosed |
| US-20110073849-A1 | METAL COMPLEXES OF CYCLOMETALLATED IMIDAZO[1,2-f ]PHENANTHRIDINE AND DIIMIDAZO[1,2-a:1',2'-c ]QUNIAZOLINE LIGANDS AND ISOELECTRONIC AND BENZANNULATED ANALOGS THEREOF | KNOWLES DAVID B | 2011-03-31 | — | — | US | disclosed |
| US-7915415-B2 | Metal complexes of cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1′,2′-c]quinazoline ligands and isoelectronic and benzannulated analogs thereof | UNIVERSAL DISPLAY CORPORATION (US) | 2011-03-29 | — | — | US | disclosed |
| EP-2243785-A1 | Phosphorescent condensed ring carbene metal complexes for use in organic light emitting devices | Universal Display Corporation (US) | 2010-10-27 | — | — | EP | disclosed |
| WO-2008156879-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080297033-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | UNIVERSAL DISPLAY CORPORATION | 2008-12-04 | — | — | US | disclosed |
| US-20070190359-A1 | Metal complexes of cyclometallated imidazo[1,2-ƒ]phenanthridine and diimidazo[1,2-a:1',2'-c]quinazoline ligands and isoelectronic and benzannulated analogs thereof | UNIVERSAL DISPLAY CORPORATION | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110073849-A1 | METAL COMPLEXES OF CYCLOMETALLATED IMIDAZO[1,2-f ]PHENANTHRIDINE AND DIIMIDAZO[1,2-a:1',2'-c ]QUNIAZOLINE LIGANDS AND ISOELECTRONIC AND BENZANNULATED ANALOGS THEREOF | NDUFC1, CD274, CRY1 | CDK8 2050/4885ROCK1 2411/4885CHEK1 1507/4885 |
| US-11744142-B2 | Organic electroluminescent materials and devices | TLL1, TLL2, ALPL | CDK8 3779/4885ROCK1 4729/4885CHEK1 4639/4885 |
| US-20240090312-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TLL1, TLL2, ALPL | CDK8 3779/4885ROCK1 4729/4885CHEK1 4639/4885 |
| US-11495754-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, EML4 | CDK8 3458/4885ROCK1 3859/4885CHEK1 3597/4885 |
| US-20080297033-A1 | BLUE PHOSPHORESCENT IMIDAZOPHENANTHRIDINE MATERIALS | IK, CRY1, MAP1LC3C | CDK8 1335/4885ROCK1 2955/4885CHEK1 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.